Press Release
M3 MI Partners with MedFuse to Empower Research Solutions with Deeper Insights into Physician and Patient Attitudes and Behaviors
Fort Washington, PA – 11.22.24– M3 MI, a leading provider of syndicated research for the healthcare industry, is pleased to announce its strategic partnership with MedFuse, a healthcare data technology company known for its extensive real-world data (RWD) solutions. This collaboration aims to enhance the depth and precision of insights on physician behaviors and attitudes available to M3 MI clients, thereby empowering healthcare brands with more targeted and actionable intelligence.
M3 MI syndicated studies provide pharma marketers with a foundational understanding of healthcare professionals’ (HCP) media usage, content preferences, perceptions of promotional activity and prescribing decision motivators, to support their marketing strategy and advertising planning efforts. Almost 20,000 HCPs across 38 medical/surgical specialties and other health verticals are interviewed annually for these studies.
Higher quality connected data leads to better analysis and outcomes for pharma marketers
In the initial phase of this relationship, select MedFuse RWD – including prescribing, diagnosis and procedure data – will be appended to M3 MI’s syndicated omnichannel preference and usage studies at a respondent level, and updated throughout the year.
“MedFuse is able to offer unparalleled data coverage by connecting multiple sources of RWD for the market’s most comprehensive view of physician activity,” states MedFuse CEO, Kevin Jones.
The combination of this robust RWD with the self-reported attitudinal and behavioral data from the M3 MI studies will enable M3 MI clients to fine tune their analysis, segmentation and targeting for more relevant insights that drive the success of their brands.
Marketers will be able to create targeted analyses using 125 high value Rx, 175 diagnosis and 140 procedural claims categories in conjunction with the thousands of data points available from the syndicated research, for an unparalleled perspective on the physician market; custom data appends and list matching to meet specific client needs will also be available.
“The decision to partner with MedFuse was driven by their ability to not only provide expansive data coverage but also to seamlessly integrate RWD in ways that enhance the strategic insights our customers rely on,” comments Dave Emery, Managing Director at M3 MI. “We’re excited about expanding this relationship, leveraging MedFuse’s real-world data expertise and our trusted survey-based patient and HCP marketing intelligence, to help clients better understand their customers and connect their analysis, planning, activation and measurement activities.”
About M3 MI
M3 MI is a leading provider of syndicated audience research and advertising intelligence for the healthcare industry, and 100% opt-in, privacy safe health audiences for activation. We help pharma and other health brands and their marketing and media partners better understand their patient and HCP customers and how to best connect and communicate with them. M3 MI (formerly Kantar Media Healthcare Research) is part of M3, Inc., a global research and data company focused 100% on health and driven by technology. For more information, visit www.M3-Mi.com or contact info@M3-Mi.com.
About MedFuse
MedFuse is a healthcare data technology company that creates value for client-partners by combining one of the most complete real-world healthcare databases with a modern technology platform and tools. Led by industry veterans with over 40 years of experience in delivering claims data solutions, MedFuse works with client-partners to leverage rich data resources to reduce costs, increase revenue, and contribute to population health. For more information, visit www.medfuse.com or contact media@medfuse.com.
For media inquiries, please contact:
Danielle Stewart, Marketing Manager
DStewart@M3MR.com